Enzyme Overseas Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.44 M
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth -44.97%
- Profit Growth -194.56%
- Ebitda -104.89%
- Net Worth -27.83%
- Total Assets -26.79%
About Enzyme Overseas
Enzyme Overseas Private Limited (EOPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 1996 and has a history of 28 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.44 M.
The company currently has active open charges totaling ₹0.50 M.
Azmat Sikand and Pooja Sikand serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51109DL1996PTC082086
- Company No.
082086
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Enzyme Overseas?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Sikand  | Director | 19-Sep-1996 | Current |
| Azmat Sikand | Director | 19-Sep-1996 | Current |
Financial Performance of Enzyme Overseas.
Enzyme Overseas Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.97% decrease. The company also saw a substantial fall in profitability, with a 194.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enzyme Overseas?
Unlock access to Enzyme Overseas's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Admi Promotions Private LimitedAzmat Sikand is a mutual person
Supremia India Private LimitedAzmat Sikand and Pooja Sikand are mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Bombay Mercantile Coop Bank Ltd. : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2003 | Bombay Mercantile Coop Bank Ltd. | ₹0.50 M | Open |
How Many Employees Work at Enzyme Overseas?
Unlock and access historical data on people associated with Enzyme Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enzyme Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzyme Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.